Skip to main content
Erschienen in: Calcified Tissue International 4/2023

04.01.2023 | Original Research

The Association of Cardiovascular Diseases Risk Scores and Osteosarcopenia Among Older Adult Populations: The Results of Bushehr Elderly Health (BEH) Program

verfasst von: Noushin Fahimfar, Hanieh Parsaiyan, Kazem Khalagi, Gita Shafiee, Mahnaz Sanjari, Mohammad Javad Mansourzadeh, Iraj Nabipour, Bagher Larijani, Davood Khalili, Afshin Ostovar

Erschienen in: Calcified Tissue International | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Considering the association of cardiovascular disease (CVD) with both osteoporosis and sarcopenia, this study aimed to explore the association between a newly developed CVD risk score and osteosarcopenia in the elderly population. Participants in the second phase of the Bushehr Elderly Health (BEH) program were included. Osteosarcopenia was defined as having both osteopenia/osteoporosis and sarcopenia. The 10-year CVD risk score was estimated using the WHO lab-based model. The participants were considered as high-risk if the CVD risk was ≥ 20%. The estimated risks were compared in individuals with and without osteosarcopenia. The association of CVD risk and osteosarcopenia was investigated using a logistic regression model, adjusted by potential confounders. In all, 2392 participants (1161 men) with a mean age of 69.3 (± 6.3) years were studied and 532 [242 (45.5%) men] individuals were diagnosed with osteosarcopenia. The median (IQR) CVD risks were 0.340 (0.214) and 0.229 (0.128) in men with and without osteosarcopenia, respectively (P < 0.001); In women, the corresponding values were 0.260 (0.147) and 0.207 (0.128), respectively (P < 0.001). Adjusted by confounders, CVD risk ≥ 20% in women, increased the odds of osteosarcopenia by 72%. Body mass index showed an inverse association with osteosarcopenia in both men (0.81, 95%CI: 0.78–0.85) and women (0.66, 95%CI: 0.62–0.70). Considering the area under the ROC curve, the models showed a discriminative ability of 82% in men and 89% in women. This study displayed a significant association between WHO CVD risk score and osteosarcopenia. Due to the difficult diagnosis of osteosarcopenia, the high association of cardiovascular risk score with this disease can help identify high-risk individuals and refer them for further diagnostic procedures. Considering the high prevalence of osteosarcopenia and its complications in the older population, comprehensive strategies are needed to find high-risk populations.
Literatur
8.
Zurück zum Zitat Sadeghi M, Haghdoost AA, Bahrampour A, Dehghani M (2017) Modeling the burden of cardiovascular diseases in Iran from 2005 to 2025: the impact of demographic changes. Iran J Public Health 46(4):506–516PubMedPubMedCentral Sadeghi M, Haghdoost AA, Bahrampour A, Dehghani M (2017) Modeling the burden of cardiovascular diseases in Iran from 2005 to 2025: the impact of demographic changes. Iran J Public Health 46(4):506–516PubMedPubMedCentral
10.
Zurück zum Zitat Sarrafzadegan N, Mohammmadifard N (2019) Cardiovascular disease in Iran in the Last 40 years: prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention. Arch Iran Med 22(4):204–210PubMed Sarrafzadegan N, Mohammmadifard N (2019) Cardiovascular disease in Iran in the Last 40 years: prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention. Arch Iran Med 22(4):204–210PubMed
13.
Zurück zum Zitat Hassan EB, Duque G (2017) Osteosarcopenia: a new geriatric syndrome. Aust Fam Physician 46(11):849–85PubMed Hassan EB, Duque G (2017) Osteosarcopenia: a new geriatric syndrome. Aust Fam Physician 46(11):849–85PubMed
18.
Zurück zum Zitat Vittinghoff E, Glidden DV, Shiboski SC, McCulloch CE (2012) Regression methods in biostatistics: linear, logistic, survival, and repeated measures models. Springer, BerlinCrossRef Vittinghoff E, Glidden DV, Shiboski SC, McCulloch CE (2012) Regression methods in biostatistics: linear, logistic, survival, and repeated measures models. Springer, BerlinCrossRef
19.
Zurück zum Zitat Jewell Nicholas P (2004) Statistics for epidemiology. Chapman & Hall/CRC, Boca Raton Jewell Nicholas P (2004) Statistics for epidemiology. Chapman & Hall/CRC, Boca Raton
Metadaten
Titel
The Association of Cardiovascular Diseases Risk Scores and Osteosarcopenia Among Older Adult Populations: The Results of Bushehr Elderly Health (BEH) Program
verfasst von
Noushin Fahimfar
Hanieh Parsaiyan
Kazem Khalagi
Gita Shafiee
Mahnaz Sanjari
Mohammad Javad Mansourzadeh
Iraj Nabipour
Bagher Larijani
Davood Khalili
Afshin Ostovar
Publikationsdatum
04.01.2023
Verlag
Springer US
Erschienen in
Calcified Tissue International / Ausgabe 4/2023
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-022-01059-8

Weitere Artikel der Ausgabe 4/2023

Calcified Tissue International 4/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

Typ-2-Diabetes: Ernährungsunsicherheit vervierfacht Risiko für schwere Hypoglykämien

04.06.2024 Typ-2-Diabetes Nachrichten

Wenn ältere Menschen mit Typ-2-Diabetes Schwierigkeiten beim Beschaffen und Zubereiten von Mahlzeiten haben, geht dies mit einem deutlich gesteigerten Risiko für schwere Hypoglykämien einher.

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.